Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Managed IT Services As A Money Saving Mechanism

Successful business owners realize the importance of reducing operating costs without affecting their company’s overall performance. Saving time and money is always a fundamental business goal, and it is more important than ever in small and midsize companies...
Lloyd Ainey | September 2, 2020 |

Karuna Shares Jump 375% Higher on Phase 2 Acute Psychosis Treatment Trial Data

Shares of Karuna Therapeutics, which completed an IPO in July 2019, soared more than 375% higher today after the firm reported that its KarXT met primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia. This morning clinical-stag...
Streetwise Reports | November 19, 2019 |

Insmed Shares Trade 40% Higher on Phase 2 Top-Line Bronchiectasis Trial Data

Insmed Inc.'s shares traded higher today after the company reported positive top-line results from its Phase 2 WILLOW Study of INS1007 in patients with non-cystic fibrosis bronchiectasis. Global biopharmaceutical company Insmed Inc. (INSM:NASDAQ) , which is...
Streetwise Reports | February 4, 2020 |

Investment opportunities in America's energy pipeline needs

The Keystone XL ruckus shone a light on pipelines like never before. From the heated nature of the debate one could be forgiven for thinking that long, high-volume pipelines are something new to America. Really, that couldn't be further from the truth: The United States bu...
Marin Katusa | October 28, 2012 |

Top 5 Smart Contract Technology Platforms in 2019

Cryptocurrency is still the hot trend. The industry enjoyed a great boom in 2017 — then, Bitcoin skyrocketed, and so did almost all altcoins. ICOs also gained immense popularity, collecting more than $7 billion in investments . The trend was expected to continue in 2018, but ...
Julia Beyers | September 13, 2019 |

Tungsten: Building the next-generation of defense systems

Now, most of the world has now heard about this company, Almonty Industries . This is a leading tungsten producer with projects in Portugal and Spain, and soon to be launching production at its flagship, Sangdong Tungsten Mine in South Korea. The company recently r...
Lyndsay Malchuk | March 27, 2025 |

Achillion Pharma Shares Open 75% Higher After Alexion Buyout Offer

Shares of Achillion Pharmaceuticals are trading much higher today after the firm reported that it has agreed to be acquired by Alexion Pharmaceuticals for $930 million, or $6.30 per share in cash, along with the potential for an additional $2 per share if certain other specifi...
Streetwise Reports | October 17, 2019 |

Analyst: The Overall Gold Outlook Is 'Strongly Bullish'

Technical analyst Clive Maund examines the effects of recent geopolitical events on the precious metals markets. It has been a week of surprises since the last updates were posted. First, I had not expected Iran to retaliate following the murder of its top genera...
Streetwise Reports | January 14, 2020 |

Building a Better Covid-19 Antibody Test

ProMIS is harnessing its unique technology platform to develop a more error-free antibody test. Testing has been an Achilles heel of the coronavirus pandemic, but ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB) has partnered with Dr. Hans Frykman and the ...
Streetwise Reports | May 7, 2020 |

Saville Resources: Making Niobium Great Again

Like a Diamond in the Rough Full size / The niobium-bearing mineral pyrochlore , with the typical brown colour and, like diamonds, an octahedral habit (i.e. “square bipyramid” shape) was recovered from a piece of drill core from Saville Resour...
Stephan Bogner | February 6, 2020 |
1 2 3 4 5 6 7 8 9 10 ...